สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 18 March 2025 23:47

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

INTER PHARMA PUBLIC COMPANY LIMITED : IP

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 48 record(s) found)
NameYearStatusTypePeriodAs OfDetails
INTER PHARMA PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ230/06/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedCompanyQ230/06/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ131/03/2024
INTER PHARMA PUBLIC COMPANY LIMITED2024ReviewedCompanyQ131/03/2024
INTER PHARMA PUBLIC COMPANY LIMITED2023AuditedConsolidatedYear31/12/2023
INTER PHARMA PUBLIC COMPANY LIMITED2023AuditedCompanyYear31/12/2023
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 12 record(s) found)
DateTimeHeadingLink
25/02/202521:14Management Discussion and Analysis Yearly Ending 31 Dec 2024
14/11/202420:09Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
14/08/202419:32Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
14/05/202408:20Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
01/03/202408:01Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/11/202308:16Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
10/08/202321:00Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
12/05/202308:33Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023
28/02/202308:33Management Discussion and Analysis Yearly Ending 31 Dec 2022
11/11/202208:42Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022
Click here to display all results
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 17 March 2025